This could be augmented for PLHIV by POCT CD4 testing to identify vulnerable patients with low CD4 counts, who are likely to have a higher TB incidence and a greater mortality risk (18% with CD4 <100 cells/mm3 compared to 7% with CD4 >500 cells/mm3). This evidence concerns the gene CD4 and tuberculosis.